Course Exam
301907 VO Development of novel cancer immunotherapies (2021W)
from target identification through target validation to clinical trials
Labels
REMOTE
WHEN?
Monday
31.01.2022
digitale schriftliche Prüfungen mit offenen Fragen mittels eines Prüfungsbogens zum Download
Registration/Deregistration
Note: The time of your registration within the registration period has no effect on the allocation of places (no first come, first served).
- Registration is open from Fr 01.10.2021 09:00 to Su 30.01.2022 09:00
- Deregistration possible until Su 30.01.2022 09:00
Examiners
Information
Assessment and permitted materials
written exam
Minimum requirements and assessment criteria
100-87%: Sehr Gut ( I ); 87,99-75%: Gut (2); 74,99-62%: Befriedigend (3); 6 I ,99-50%: Genügend (4); < 50%: Nicht Genügend (5)
Last modified: Fr 12.05.2023 00:24